Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian Cells

ACS Chem Neurosci. 2020 Oct 21;11(20):3204-3213. doi: 10.1021/acschemneuro.0c00300. Epub 2020 Oct 2.

Abstract

The Alzheimer's disease related peptide, Amyloid-beta (Aβ)1-40 and 1-42, has proven difficult to be purified as a recombinant monomeric protein due its expression in E. coli leading to the formation of insoluble inclusion bodies and its tendency to quickly form insoluble aggregates. A vast array of methods have been used so far, yet many have pitfalls, such as the use of tags for ease of Aβ isolation, the formation of Aβ multimers within the time frame of extraction, or the need to reconstitute Aβ from a freeze-dried state. Here, we present a rapid protocol to produce highly pure and monomeric recombinant Aβ using a one-step ion exchange purification method and to label the peptide using a maleimide dye. The washing, solubilization, and purification steps take only 3 h. We also present a protocol for the isolation of Aβ-mCherry from mammalian cells.

Keywords: Aβ40; Aβ42; E22G; amyloid; arctic mutant; dye labeling; fluorescence; inclusion bodies; ion exchange chromatography; mCherry; maleimide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides
  • Animals
  • Escherichia coli*
  • Peptide Fragments
  • Recombinant Proteins

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • Recombinant Proteins